Fundz

Artiva Biotherapeutics Appoints Neha Krishnamohan as CFO and Executive VP, Corporate Development, and Promotes Jennifer Bush to COO

PUBLIC · ARTVApr 25, 2024

Position

Vice President of Corporate Development

Company

Artiva Biotherapeutics

Neha Krishnamohan
neha@artivabio.com
San DiegoBiotechnologyHealth CareTherapeutics

Description

Artiva Biotherapeutics, Inc. announced the appointment of Neha Krishnamohan as Chief Financial Officer and Executive Vice President, Corporate Development, and the promotion of Jennifer Bush to Chief Operating Officer

Quick answer

Artiva Biotherapeutics Appoints Neha Krishnamohan as CFO and Executive VP, Corporate Development, and Promotes Jennifer Bush to COO (April 25, 2024). Artiva Biotherapeutics is based in San Diego, California, United States.

Who is the new Vice President of Corporate Development at Artiva Biotherapeutics?
Artiva Biotherapeutics named Neha Krishnamohan Vice President of Corporate Development, announced April 25, 2024.
What did Artiva Biotherapeutics announce on April 25, 2024?
Artiva Biotherapeutics, Inc. announced the appointment of Neha Krishnamohan as Chief Financial Officer and Executive Vice President, Corporate Development, and the promotion of Jennifer Bush to Chief Operating Officer
What does Artiva Biotherapeutics do?
Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers.
Where is Artiva Biotherapeutics based?
Artiva Biotherapeutics is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Arvinas (April 24, 2024), Actym Therapeutics (April 24, 2024), Flare Therapeutics (April 23, 2024) and CureVac (April 29, 2024) also announced leadership changes within 45 days of Artiva Biotherapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Artiva Biotherapeutics, and when

A new leader at Artiva Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Artiva Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Artiva Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Artiva Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Artiva Biotherapeutics

Location

San Diego, California, United States

About

Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. Artiva’s lead program, AlloNK® (also known as AB-101), is an allogeneic, off-the-shelf, non-genetically modified, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity effect of monoclonal antibodies to drive B-cell depletion. AlloNK® is currently in clinical trials for treatment of systemic lupus erythematosus, for patients with or without lupus nephritis, and in an investigator-initiated basket trial in multiple autoimmune indications. Artiva’s pipeline also includes CAR-NK candidates targeting both solid and hematologic cancers. Artiva was founded in 2019 as a spin out of GC Cell, formerly GC Lab Cell Corporation, a leading healthcare company in the Republic of Korea, pursuant to a strategic partnership granting Artiva exclusive worldwide rights (excluding Asia, Australia and New Zealand) to GC Cell’s NK cell manufacturing technology and programs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Artiva Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Neha
Likely contact at this company
••••••••@••••••••

See Neha's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Artiva Biotherapeutics's next move

Learn about Strategic plan

Artiva Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.